Press Release


New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
May 16, 2024 22:00 JST
XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut.
More info..

New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine
Feb 06, 2024 23:00 JST

BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
Dec 22, 2023 09:00 JST

BioMed X Launches a New Call for Application in Autoimmune Disease Research
Nov 07, 2023 19:00 JST

BioMed X and AbbVie Start New Research Project in the USA
Nov 01, 2023 07:00 JST

BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus
Apr 27, 2023 20:00 JST
BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs.
More info..

BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Apr 04, 2023 17:00 JST
BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy.
More info..

Latest Release


More Latest Release >>